Across its top 1 institutional holders, ABMDEUR's holder base skews toward low-concentration, low-turnover investors on average (avg. concentration score 5/100, avg. turnover score 20/100).
Quarterly Activity
Recent Activity
+$0.0
Total Buy Value
$0.0
Total Sell Value
New buy0
Trim0
Add0
Sold out1
0
Net Buyers
1
Net Sellers
Smart Money Convergence
ABMDEUR does not currently have enough recent insider (Form 4) trading activity to compute a convergence signal against its 13F institutional flows.
13F data as of 2026-03-31 quarterly filings. Note: many large institutions file close to the 45-day post-quarter deadline, so early-quarter flow figures can shift substantially as more filings arrive.
Insider Trading (Form 4)
Form 144 Pre-Sale Notices
No Form 144 planned sale filings in the last 90 days
Beneficial Ownership (13D/13G)
No Schedule 13D/13G filings for this ticker
Material Events (8-K)
No Form 8-K filings for this ticker
CUSIP
003654100
FAQ
Who are the top institutional investors holding ABIOMED INC (ABMDEUR)?
Major stakeholders currently include Huntington National Bank ($381.0). Based on the latest 13F filings, there are a total of 1 tracked investment funds and institutions maintaining positions in ABMDEUR.
What is the overall institutional sentiment toward ABMDEUR recently?
Institutional sentiment appears Neutral. During the most recent reporting quarter, the stock experienced a flat net capital flow.
Which institutions have been selling or reducing their ABMDEUR positions?
In the latest period, 0 funds trimmed their holdings, and 1 managers completely exited their positions. The aggregate reported sell value was $0.0.
Are there any notable investors adding ABMDEUR to their portfolios?
No tracked institutions opened new positions or added to their existing holdings in ABMDEUR during the last reporting period.
Related Stocks
Trending Institutional Adds
The most-added stocks by 13F institutions this quarter